Variant report

Variant	nsv884074
Chromosome Location	chr6:30434566-30447987
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF3	chr6:30438818-30439151	K562	blood:	n/a	n/a
2	CEBPB	chr6:30438803-30439128	HepG2	liver:	n/a	chr6:30439061-30439074 chr6:30438959-30438970
3	CEBPB	chr6:30438786-30439148	K562	blood:	n/a	chr6:30439061-30439074 chr6:30438959-30438970
4	CEBPB	chr6:30438780-30439151	IMR90	lung:	n/a	chr6:30439061-30439074 chr6:30438959-30438970
5	CEBPB	chr6:30438794-30439097	A549	lung:	n/a	chr6:30439061-30439074 chr6:30438959-30438970
6	CEBPB	chr6:30438805-30439103	H1-hESC	embryonic stem cell:	n/a	chr6:30439061-30439074 chr6:30438959-30438970
7	CEBPB	chr6:30438765-30439122	K562	blood:	n/a	chr6:30439061-30439074 chr6:30438959-30438970
8	CEBPB	chr6:30438777-30439163	Hela-S3	cervix:	n/a	chr6:30439061-30439074 chr6:30438959-30438970
9	CTCF	chr6:30434420-30434570	HepG2	liver:	n/a	n/a
10	CTCF	chr6:30439665-30439743	Kidney_OC	kidney:	n/a	n/a
11	E2F6	chr6:30433915-30434639	A549	lung:	n/a	n/a
12	ELF1	chr6:30434481-30434759	K562	blood:	n/a	n/a
13	ELF1	chr6:30434329-30434755	K562	blood:	n/a	n/a
14	ELF1	chr6:30433919-30434800	GM12878	blood:	n/a	chr6:30434031-30434044 chr6:30434033-30434042
15	EP300	chr6:30438808-30439053	Hela-S3	cervix:	n/a	chr6:30438960-30438974
16	EP300	chr6:30438886-30439072	K562	blood:	n/a	chr6:30438960-30438974 chr6:30439050-30439060
17	FAM48A	chr6:30447891-30447964	GM12878	blood:	n/a	n/a
18	FOS	chr6:30447832-30448128	MCF10A-Er-Src	breast:	n/a	chr6:30447979-30447988
19	FOS	chr6:30447815-30448125	MCF10A-Er-Src	breast:	n/a	chr6:30447979-30447988
20	FOS	chr6:30447811-30448127	MCF10A-Er-Src	breast:	n/a	chr6:30447979-30447988
21	FOS	chr6:30447837-30448073	MCF10A-Er-Src	breast:	n/a	chr6:30447979-30447988
22	GABPA	chr6:30433964-30434682	MCF-7	breast:	n/a	n/a
23	JUN	chr6:30447972-30447995	H1-hESC	embryonic stem cell:	n/a	chr6:30447979-30447988
24	JUN	chr6:30438794-30439088	HepG2	liver:	n/a	chr6:30438960-30438973
25	JUND	chr6:30438834-30439096	HepG2	liver:	n/a	n/a
26	JUND	chr6:30438844-30439033	K562	blood:	n/a	n/a
27	JUND	chr6:30447932-30448040	HepG2	liver:	n/a	chr6:30447979-30447988 chr6:30447977-30447988
28	MAX	chr6:30434330-30434635	K562	blood:	n/a	n/a
29	MAX	chr6:30433902-30434948	A549	lung:	n/a	n/a
30	MAX	chr6:30433688-30434841	K562	blood:	n/a	chr6:30433883-30433894 chr6:30433880-30433895 chr6:30433885-30433894
31	MAX	chr6:30433962-30434788	A549	lung:	n/a	n/a
32	MTA3	chr6:30434185-30434665	GM12878	blood:	n/a	n/a
33	MYC	chr6:30438881-30438931	H1-hESC	embryonic stem cell:	n/a	n/a
34	MYC	chr6:30435066-30435119	GM12878	blood:	n/a	n/a
35	MYC	chr6:30447979-30448086	MCF10A-Er-Src	breast:	n/a	n/a
36	NR2F2	chr6:30443290-30443770	K562	blood:	n/a	n/a
37	NR2F2	chr6:30443387-30443754	K562	blood:	n/a	n/a
38	PAX5	chr6:30442332-30442564	GM12878	blood:	n/a	n/a
39	POLR2A	chr6:30440194-30440304	ProgFib	skin:	n/a	n/a
40	POLR2A	chr6:30436614-30436773	ProgFib	skin:	n/a	n/a
41	RUNX3	chr6:30434303-30434818	GM12878	blood:	n/a	n/a
42	RUNX3	chr6:30434325-30434711	GM12878	blood:	n/a	n/a
43	STAT3	chr6:30447901-30448022	MCF10A-Er-Src	breast:	n/a	n/a
44	UBTF	chr6:30433976-30434784	K562	blood:	n/a	n/a
45	UBTF	chr6:30433757-30434658	K562	blood:	n/a	n/a
46	ZNF263	chr6:30435081-30435395	HEK293-T-REx	kidney:	n/a	chr6:30435186-30435207
47	ZNF384	chr6:30434501-30434926	K562	blood:	n/a	n/a
48	ZNF384	chr6:30434595-30434937	GM12878	blood:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:30434552-30434602	RPTEC	kidney:	n/a
2	chr6:30434552-30434602	MCF10A-Er-Src	breast:	n/a
3	chr6:30434523-30434573	NH-A	brain:	n/a
4	chr6:30434523-30434573	AG04449	skin:	fetal
5	chr6:30434523-30434573	AG09309	skin:	n/a
6	chr6:30434552-30434602	HUVEC	blood vessel:	n/a
7	chr6:30434523-30434573	HIPEpiC	eye:	n/a
8	chr6:30434523-30434573	HL-60	blood:	n/a
9	chr6:30434523-30434573	HepG2	liver:	n/a
10	chr6:30434523-30434573	HCT-116	colon:	n/a
11	chr6:30434523-30434573	GM06990	blood:	n/a
12	chr6:30437493-30437543	NB4	blood:	n/a
13	chr6:30434525-30434575	HRE	kidney:	n/a
14	chr6:30434523-30434573	AG04450	lung:	fetal
15	chr6:30437493-30437543	HEK293	kidney:	embryo
16	chr6:30434525-30434575	NH-A	brain:	n/a
17	chr6:30437493-30437543	HAEpiC	amniotic membrane:	n/a
18	chr6:30434552-30434602	H1-hESC	embryonic stem cell:	embryo
19	chr6:30434523-30434573	LNCaP	prostate:	n/a
20	chr6:30437493-30437543	U87	brain:	n/a
21	chr6:30434523-30434573	BE2_C	brain:	n/a
22	chr6:30437493-30437543	HUVEC	blood vessel:	n/a
23	chr6:30434525-30434575	AG04449	skin:	fetal
24	chr6:30434552-30434602	HEEpiC	esophagus:	n/a
25	chr6:30434525-30434575	AG09319	gingival:	n/a
26	chr6:30434525-30434575	MCF-7	breast:	n/a
27	chr6:30437493-30437543	MCF-7	breast:	n/a
28	chr6:30434552-30434602	HL-60	blood:	n/a
29	chr6:30434523-30434573	HCM	heart:	n/a
30	chr6:30434525-30434575	HEK293	kidney:	embryo
31	chr6:30434525-30434575	NHBE	bronchial:	n/a
32	chr6:30437493-30437543	SK-N-SH_RA	brain:	n/a
33	chr6:30434525-30434575	GM12878	blood:	n/a
34	chr6:30434552-30434602	Caco-2	colon:	n/a
35	chr6:30434523-30434573	SAEC	small airway:	n/a
36	chr6:30434552-30434602	GM19239	blood:	n/a
37	chr6:30437493-30437543	GM06990	blood:	n/a
38	chr6:30434523-30434573	PANC-1	pancreas:	n/a
39	chr6:30437493-30437543	Caco-2	colon:	n/a
40	chr6:30434552-30434602	GM12891	blood:	n/a
41	chr6:30434523-30434573	MCF10A-Er-Src	breast:	n/a
42	chr6:30434523-30434573	MCF-7	breast:	n/a
43	chr6:30434525-30434575	AG09309	skin:	n/a
44	chr6:30434525-30434575	PANC-1	pancreas:	n/a
45	chr6:30437493-30437543	AG09319	gingival:	n/a
46	chr6:30434552-30434602	HepG2	liver:	n/a
47	chr6:30434525-30434575	Jurkat	blood:	n/a
48	chr6:30434525-30434575	MCF10A-Er-Src	breast:	n/a
49	chr6:30434523-30434573	GM12878	blood:	n/a
50	chr6:30434525-30434575	GM12892	blood:	n/a

No.	Distal block	Cell Line	Cell type
1	chr6:30433130..30435301-chr6:30582917..30586018,4	MCF-7	breast:
2	chr6:30428958..30430493-chr6:30439620..30441525,2	MCF-7	breast:
3	chr6:30447476..30449412-chr6:30509865..30511998,2	K562	blood:
4	chr6:30446309..30448997-chr6:30451629..30454419,2	MCF-7	breast:
5	chr6:30447949..30451648-chr6:30569801..30572499,4	MCF-7	breast:
6	chr6:30446515..30448275-chr6:30457111..30458820,2	K562	blood:
7	chr6:30446384..30451689-chr6:30578094..30585004,12	MCF-7	breast:
8	chr6:30431634..30435485-chr6:30582972..30586314,3	K562	blood:
9	chr6:30447797..30449612-chr6:30512660..30515323,2	MCF-7	breast:
10	chr6:30447631..30450065-chr6:30691817..30695001,3	K562	blood:

Variant related genes	Relation type
SUCLA2P1	TF binding region
SUCLA2P1	CpG island
ENSG00000204568	chromatin interactions
ENSG00000222894	chromatin interactions
ENSG00000204569	chromatin interactions
ENSG00000204592	chromatin interactions
ENSG00000236603	chromatin interactions

Extended variants
information (count: 97 )
Associated
traits (count: 121 )

Variant overlapped rSNPs/rCNVs (count:97 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs7764934	chr6:30434566-30434567	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs180746900	chr6:30434594-30434595	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
3	rs557950511	chr6:30434708-30434709	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
4	rs373752199	chr6:30434729-30434730	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
5	rs527622265	chr6:30434788-30434789	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
6	rs60519056	chr6:30434819-30434820	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
7	rs9278690	chr6:30434831-30434832	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
8	rs12175296	chr6:30434833-30434834	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
9	rs7747740	chr6:30434840-30434841	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
10	rs577287637	chr6:30434864-30434865	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
11	rs7747873	chr6:30434900-30434901	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS	TF binding region Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
12	rs562925433	chr6:30434901-30434902	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
13	rs149979124	chr6:30434928-30434929	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
14	rs542506472	chr6:30434935-30434936	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
15	rs562196089	chr6:30434965-30434966	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
16	rs527996396	chr6:30434972-30434973	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
17	rs187434329	chr6:30434986-30434987	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
18	rs2516670	chr6:30434999-30435000	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
19	rs533450148	chr6:30435006-30435007	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
20	rs528399998	chr6:30435069-30435070	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
21	rs145215704	chr6:30435123-30435124	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
22	rs570065709	chr6:30435139-30435140	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
23	rs149163531	chr6:30435175-30435176	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
24	rs200572169	chr6:30435183-30435184	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
25	rs565804223	chr6:30435199-30435200	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
26	rs377621235	chr6:30435250-30435251	Bivalent Enhancer Enhancers Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
27	rs201572242	chr6:30435252-30435253	Bivalent Enhancer Enhancers Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
28	rs373744159	chr6:30435256-30435257	Bivalent Enhancer Enhancers Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
29	rs557506558	chr6:30435257-30435258	Bivalent Enhancer Enhancers Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
30	rs6930977	chr6:30435288-30435289	Bivalent Enhancer Enhancers Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
31	rs568284987	chr6:30435398-30435399	Bivalent Enhancer Enhancers Bivalent/Poised TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
32	rs556684427	chr6:30435443-30435444	Bivalent Enhancer Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
33	rs142300195	chr6:30435453-30435454	Bivalent Enhancer Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
34	rs542216840	chr6:30435458-30435459	Bivalent Enhancer Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
35	rs559315383	chr6:30435470-30435471	Bivalent Enhancer Enhancers	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
36	rs557751463	chr6:30435509-30435510	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs555047141	chr6:30435562-30435563	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs527957962	chr6:30435621-30435622	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
39	rs546665058	chr6:30435631-30435632	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
40	rs375920180	chr6:30435674-30435675	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
41	rs147905164	chr6:30435751-30435752	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
42	rs533614315	chr6:30435776-30435777	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
43	rs191810662	chr6:30435778-30435779	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
44	rs2516669	chr6:30435801-30435802	Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
45	rs560380794	chr6:30435862-30435863	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
46	rs547616599	chr6:30435873-30435874	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
47	rs115794740	chr6:30435878-30435879	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
48	rs12214645	chr6:30435930-30435931	Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
49	rs115164168	chr6:30435945-30435946	Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
50	rs115787549	chr6:30446493-30446494	Inactive region	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:121)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
Lung cancer	18438408	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	21448237	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Cancer	20164919	CNVD
Melanoma	18172304	CNVD
Breast cancer	22844521	CNVD
HIV/AIDS	22844521	CNVD
Ovarian cancer	22844521	CNVD
Prostate cancer	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
Breast cancer	22522925	CNVD
Ovarian cancer	21781307	CNVD
Breast cancer	21552322	CNVD
Immune disease	21076436	CNVD
Autoimmune disease	19135723	CNVD
Systemic lupus erythematosus	17953491	CNVD
Recurrent Infections	22737222	CNVD
Systemic lupus erythematosus	21904924	CNVD
Ependymoma	19289631	CNVD
Gestational infection	22844521	CNVD
Head circumference	22844521	CNVD
Infertility	22844521	CNVD
Recurrent birth weight diabetes	22844521	CNVD
Obesity	22844521	CNVD
Recurrent pregnancy loss	22844521	CNVD
Intellectual disability	21811512	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Congenital anomalies of the kidney and urinary tract	18694510	CNVD
Nasopharyngeal cancer	22815911	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	21115979	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Autism	22495311	CNVD
Cancer	16790693	CNVD
Cervical cancer	21062161	CNVD
Breast cancer	21785460	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Systemic lupus erythematosus	17503323	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Urothelial carcinoma	18382360	CNVD
Cancer	21183584	CNVD
Hodgkin''s lymphoma	17606441	CNVD
small cell lung cancer	20016488	CNVD
Renal cell carcinoma	18765545	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Gastric cancer	17908304	CNVD
Metanephric adenoma	20802469	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Schizophrenia	19571808	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Neuroblastoma	16790693	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
abnormal development	18461090	CNVD
Melanoma	17363583	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16397240	CNVD
Retinoblastoma	22278416	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Systemic lupus erythematosus	20877625	CNVD
Cleidocranial dysplasia	18696259	CNVD
Holoprosencephaly	21359414	CNVD
Liposarcoma	21253554	CNVD
Uveal melanoma	20484589	CNVD
Fibroblasts	20926602	CNVD
Breast cancer	21364760	CNVD
Lung cancer	21569311	CNVD
Systemic lupus erythematosus	19279649	CNVD
Retinoblastoma	16790693	CNVD
Acute myocardial infarction	18032375	CNVD
Renal cell carcinoma	19150565	CNVD
Systemic lupus erythematosus	19591781	CNVD
Attention deficit hyperactivity disorder	19287146	CNVD
Autism	19287146	CNVD
Erythema nodosum in leprosy	19287146	CNVD
Henoch-schoenlein purpura	19287146	CNVD
Liver cirrhosis	19287146	CNVD
Systemic lupus erythematosus	19287146	CNVD
Congenital adrenal hyperplasia	18478071	CNVD
Systemic lupus erythematosus	19287147	CNVD
Osteosarcoma	16790693	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:206 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:30433200-30434800	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
2	chr6:30433800-30434600	Enhancers	Lung	lung
3	chr6:30433800-30434600	Bivalent/Poised TSS	Psoas Muscle	Psoas
4	chr6:30433800-30434800	Bivalent/Poised TSS	H1 Cell Line	embryonic stem cell
5	chr6:30433800-30434800	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
6	chr6:30433800-30434800	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
7	chr6:30433800-30434800	Flanking Bivalent TSS/Enh	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
8	chr6:30433800-30434800	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin01	Skin
9	chr6:30433800-30434800	Bivalent/Poised TSS	Brain Hippocampus Middle	brain
10	chr6:30433800-30434800	Bivalent/Poised TSS	Brain Inferior Temporal Lobe	brain
11	chr6:30433800-30434800	Flanking Bivalent TSS/Enh	Duodenum Mucosa	Duodenum
12	chr6:30433800-30434800	Flanking Bivalent TSS/Enh	Fetal Brain Female	brain
13	chr6:30433800-30434800	Bivalent Enhancer	Fetal Kidney	kidney
14	chr6:30433800-30434800	Flanking Bivalent TSS/Enh	Skeletal Muscle Male	skeletal muscle
15	chr6:30433800-30434800	Flanking Bivalent TSS/Enh	HUVEC	blood vessel
16	chr6:30433800-30435000	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
17	chr6:30433800-30435000	Flanking Bivalent TSS/Enh	Primary T regulatory cells fromperipheralblood	blood
18	chr6:30434000-30434600	Bivalent/Poised TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
19	chr6:30434000-30434600	Flanking Bivalent TSS/Enh	iPS DF 6.9 Cell Line	embryonic stem cell
20	chr6:30434000-30434600	Bivalent/Poised TSS	ES-UCSF4 Cell Line	embryonic stem cell
21	chr6:30434000-30434600	Flanking Bivalent TSS/Enh	Cortex derived primary cultured neurospheres	brain
22	chr6:30434000-30434600	Bivalent/Poised TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
23	chr6:30434000-30434600	Flanking Bivalent TSS/Enh	Brain Germinal Matrix	brain
24	chr6:30434000-30434600	Bivalent/Poised TSS	Colon Smooth Muscle	Colon
25	chr6:30434000-30434600	Active TSS	Ovary	ovary
26	chr6:30434000-30434600	Bivalent/Poised TSS	Sigmoid Colon	Sigmoid Colon
27	chr6:30434000-30434600	Flanking Bivalent TSS/Enh	HepG2	liver
28	chr6:30434000-30434800	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
29	chr6:30434000-30434800	Bivalent/Poised TSS	ES-WA7 Cell Line	embryonic stem cell
30	chr6:30434000-30434800	Bivalent/Poised TSS	H9 Cell Line	embryonic stem cell
31	chr6:30434000-30434800	Bivalent/Poised TSS	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
32	chr6:30434000-30434800	Flanking Bivalent TSS/Enh	H9 Derived Neuron Cultured Cells	ES cell derived
33	chr6:30434000-30434800	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
34	chr6:30434000-30434800	Flanking Bivalent TSS/Enh	IMR90 fetal lung fibroblasts Cell Line	lung
35	chr6:30434000-30434800	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
36	chr6:30434000-30434800	Bivalent/Poised TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
37	chr6:30434000-30434800	Flanking Bivalent TSS/Enh	Breast Myoepithelial Primary Cells	Breast
38	chr6:30434000-30434800	Flanking Bivalent TSS/Enh	Primary T helper cells PMA-I stimulated	--
39	chr6:30434000-30434800	Flanking Bivalent TSS/Enh	Primary T helper 17 cells PMA-I stimulated	--
40	chr6:30434000-30434800	Bivalent/Poised TSS	Primary T cells effector/memory enriched fromperipheralblood	blood
41	chr6:30434000-30434800	Flanking Bivalent TSS/Enh	Ganglion Eminence derived primary cultured neurospheres	brain
42	chr6:30434000-30434800	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin02	Skin
43	chr6:30434000-30434800	Flanking Active TSS	Foreskin Melanocyte Primary Cells skin03	Skin
44	chr6:30434000-30434800	Flanking Bivalent TSS/Enh	Primary mononuclear cells fromperipheralblood	Blood
45	chr6:30434000-30434800	Bivalent/Poised TSS	Brain Cingulate Gyrus	brain
46	chr6:30434000-30434800	Flanking Bivalent TSS/Enh	Colonic Mucosa	Colon
47	chr6:30434000-30434800	Flanking Bivalent TSS/Enh	Fetal Adrenal Gland	Adrenal Gland
48	chr6:30434000-30434800	Flanking Bivalent TSS/Enh	Left Ventricle	heart
49	chr6:30434000-30434800	Flanking Bivalent TSS/Enh	Rectal Mucosa Donor 31	rectum
50	chr6:30434000-30434800	Bivalent/Poised TSS	Rectal Smooth Muscle	rectum

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links